|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
C61 |
Malignant neoplasm of prostate
Diagnosis Valid for Male Patient Only
|
C61 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 62.36%
|
20.82%
|
6.40%
|
3.58%
|
2.26%
|
1.54%
|
0.98%
|
0.66%
|
0.44%
|
0.30%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C61*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
84153
|
ASSAY OF PSA TOTAL |
519,474
|
519,549
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
493,590
|
495,010
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
371,352
|
372,322
|
|
77385
|
NTSTY MODUL RAD TX DLVR SMPL |
285,351
|
285,505
|
|
80053
|
COMPREHEN METABOLIC PANEL |
255,635
|
255,642
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
246,151
|
246,223
|
|
84403
|
ASSAY OF TOTAL TESTOSTERONE |
120,083
|
120,327
|
|
96402
|
CHEMO HORMON ANTINEOPL SQ/IM |
85,184
|
86,259
|
|
J9217
|
LEUPROLIDE ACETATE SUSPNSION |
82,347
|
289,178
|
|
78306
|
BONE IMAGING WHOLE BODY |
71,851
|
71,853
|
|
77336
|
RADIATION PHYSICS CONSULT |
65,166
|
65,180
|
|
A9503
|
TC99M MEDRONATE |
61,849
|
62,251
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
55,826
|
5,560,852
|
|
80048
|
METABOLIC PANEL TOTAL CA |
51,948
|
52,071
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
42,873
|
45,730
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
42,391
|
42,397
|
|
85027
|
COMPLETE CBC AUTOMATED |
42,220
|
42,438
|
|
J3010
|
FENTANYL CITRATE INJECTION |
41,376
|
72,479
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
40,818
|
177,302
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
40,285
|
1,202,563
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C61 related to the following DRG Codes:
715-716
722-724
|
